Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
15 Apr 24
DEFA14A
Additional proxy soliciting materials
15 Apr 24
DEF 14A
Definitive proxy
15 Apr 24
S-8
Registration of securities for employees
28 Mar 24
10-K
2023 FY
Annual report
15 Mar 24
8-K
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial ResultsĀ and Provides Current Business Update
13 Mar 24
8-K
Completion of Acquisition or Disposition of Assets
4 Mar 24
8-K
Departure of Directors or Certain Officers
22 Feb 24
8-K
Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP
5 Feb 24
8-K
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
22 Jan 24
8-K
Results of Operations and Financial Condition
9 Jan 24
8-K
Other Events
9 Jan 24
8-K
Other Events
26 Dec 23
8-K
Departure of Directors or Certain Officers
11 Dec 23
8-K
Departure of Directors or Certain Officers
7 Dec 23
8-K
Regulation FD Disclosure
27 Nov 23
8-K/A
Financial Statements and Exhibits
13 Nov 23
10-Q
2023 Q3
Quarterly report
6 Nov 23
8-K
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
6 Nov 23
8-K/A
Report of Independent Registered Public Accounting Firm
6 Nov 23
8-K
Regulation FD Disclosure
27 Oct 23
8-K
Entry into a Material Definitive Agreement
27 Oct 23
8-K
Unregistered Sales of Equity Securities
6 Oct 23
8-K
Entry into a Material Definitive Agreement
12 Sep 23
424B5
Prospectus supplement for primary offering
12 Sep 23
8-K
Coherus Completes Surface Oncology Acquisition
8 Sep 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
8-K
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
2 Aug 23
EFFECT
Notice of effectiveness
27 Jul 23
424B3
Prospectus supplement
26 Jul 23
CORRESP
Correspondence with SEC
24 Jul 23
8-K
Departure of Directors or Certain Officers
20 Jul 23
UPLOAD
Letter from SEC
14 Jul 23
S-4
Registration of securities issued in business combination transactions
7 Jul 23
425
Business combination disclosure
16 Jun 23
425
Business combination disclosure
16 Jun 23
425
Business combination disclosure
16 Jun 23
425
Business combination disclosure
16 Jun 23
425
Business combination disclosure
16 Jun 23
Latest ownership filings
4
Georgia Erbez
22 Feb 24
3
Georgia Erbez
22 Feb 24
4
Mats Wahlstrom
15 Feb 24
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 24
SC 13G/A
ALLIANCEBERNSTEIN L.P.
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
Mats Wahlstrom
5 Feb 24
SC 13G/A
BlackRock Inc.
24 Jan 24
4
Dennis M Lanfear
23 Jan 24
4
Paul Reider
23 Jan 24
4
Bryan J McMichael
23 Jan 24
SC 13G/A
STATE STREET CORP
22 Jan 24
4
Bryan J McMichael
9 Jan 24
4
Dennis M Lanfear
8 Jan 24
4
Paul Reider
8 Jan 24
4
Bryan J McMichael
4 Jan 24
4
Paul Reider
4 Jan 24
4
McDavid Stilwell
3 Jan 24
4
Paul Reider
15 Dec 23
SC 13G/A
JPMORGAN CHASE & CO
7 Dec 23
4
Dennis M Lanfear
24 Nov 23
144
Notice of proposed sale of securities
22 Nov 23
SC 13G/A
BlackRock Inc.
6 Oct 23
4
Michael Lee Ryan
20 Jul 23
3
Michael Lee Ryan
20 Jul 23
4
Dennis M Lanfear
15 Jun 23
4
Bryan J McMichael
15 Jun 23
4
McDavid Stilwell
15 Jun 23
4
Paul Reider
15 Jun 23
4
Mats Wahlstrom
9 Jun 23
4
MARK STOLPER
9 Jun 23
4
Lee Nisley Newcomer
9 Jun 23
4
KIMBERLY JO TZOUMAKAS
9 Jun 23
4
Jill O'Donnell-Tormey
9 Jun 23
4
Charles W. Newton
9 Jun 23
SC 13G
CITADEL ADVISORS LLC
19 May 23
4
Vladimir Vexler
4 Apr 23
4
Paul Reider
4 Apr 23
4
McDavid Stilwell
4 Apr 23
4
Bryan J McMichael
29 Mar 23